Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVI... | ResearchHub

Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

0

Authors

Rebecca Haberman

Rebecca Haberman•Ramin Herati•Jose Scher

Published

May 25, 2021

Abstract

To investigate the humoral and cellular immune response to messenger RNA (mRNA) COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment.

Supporters

Support the authors with ResearchCoin

Journal

Annals of the Rheumatic Diseases

Topics

Cancer Oncology

DOI

10.1136/annrheumdis-2021-220597

License

Supporters

Support the authors with ResearchCoin

Journal

Annals of the Rheumatic Diseases

Topics

Cancer Oncology

DOI

10.1136/annrheumdis-2021-220597

License